Xuebijing Protects Against Septic Acute Liver Injury Based on Regulation of GSK-3β Pathway

Xuebijing (XBJ), the only drug approved for the sepsis and multiple organ dysfunction, and its protective effects against acute liver injury (ALI) and its mechanism. The aim of this study was to evaluate the protective effect of XBJ on cecal ligation and perforation (CLP)-induced mouse ALI model and...

Descripción completa

Detalles Bibliográficos
Autores principales: Cao, Liping, Li, Zhenghong, Ren, Yi, Wang, Mengmeng, Yang, Zhizhou, Zhang, Wei, Han, Xiaoqin, Yao, Mengya, Sun, Zhaorui, Nie, Shinan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120308/
https://www.ncbi.nlm.nih.gov/pubmed/33995024
http://dx.doi.org/10.3389/fphar.2021.627716

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8120308/
https://www.ncbi.nlm.nih.gov/pubmed/33995024
http://dx.doi.org/10.3389/fphar.2021.627716

Ejemplares similares